Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 188

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Some Coronary Risk Factors Related to the Insulin Resistance Syndrome and Treatment With Gemfibrozil: Experience From the Helsinki Heart Study

Tenkanen, Leena, Mänttäri, Matti, Manninen, Vesa · 1995 · Circulation

Abstract

Background Coronary risk factors related to the insulin resistance syndrome tend to cluster in the same individual. Our previous studies have shown that the dyslipidemia characteristic of this syndrome—low HDL cholesterol and high triglyceride (TG) levels—responds well to treatment with gemfibrozil. Most factors related to insulin-resistance syndrome decrease fibrinolytic capacity, whereas a recent study showed that gemfibrozil improves it and thus may attenuate thrombotic events. To discover whether subjects with clustering of factors related to this resistance might in particular benefit from gemfibrozil, we reanalyzed the Helsinki Heart Study data. Methods and Results We used Cox regression models to explore the effects of gemfibrozil among overweight subjects with additional coronary risk factors in this hypercholesterolemic male population of 2046 subjects randomized to gemfibrozil and 2035 to placebo. The effect of gemfibrozil was largely confined to overweight subjects: among those with body mass index (BMI) >26 kg/m 2 , the net difference in cardiac end points between gemfibrozil and placebo groups was 21 (25 of 1119 versus 46 of 1081), and in those with BMI ≤26 kg/m 2 , it was 7 (31 of 927 versus 38 of 954). The risk reduction with gemfibrozil was 78% ( P =.002) among those with BMI >26 kg/m 2 and dyslipidemia (TG ≥2.3 mmol/L and HDL cholesterol <1.08 mmol/L). Among those with BMI >26 kg/m 2 and three or four of the following factors present—smoking, sedentary lifestyle, blood pressure ≥140/90 mm Hg, or blood glucose >4.4 mmol/L—the risk reduction was 68% ( P =.03). Conclusions Gemfibrozil reduced the coronary risk mainly in overweight subjects with additional risk factors known to contribute to the insulin-resistance syndrome or predispose to it.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.cir.92.7.1779

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 25

  1. 10.7326/0003-4819-103-6-1010 · DOI · Paper page
  2. 10.3109/07853899209164140 · DOI · Paper page
  3. Stanton JL Braitman LE Riley AM Khoo C-S Smith JL. Demographic dietary life style and anthropometric correlates of blood pressure. Hypertension. 1982;4(suppl III):III-135-III-142. · DOI
  4. 10.2337/diab.41.7.826 · DOI · Paper page
  5. 10.2337/diab.37.12.1595 · DOI · Paper page
  6. 10.1016/0140-6736(92)90730-Q · DOI · Paper page
  7. 10.1016/0002-9149(92)90981-4 · DOI
  8. Juhan-Vague I, Vague P, Alessi MC, Badier C, Valadier Aillaud MF, Atlan C. Relationships between plasma insulin, triglyceride, body mass index, and plasminogen activator inhibitor 1. Diabetes Metab. 1987;13:331-336.
  9. 10.1161/atv91.12.3.1547186 · doi:10.1161/atv91.12.3.1547186
  10. 10.1161/circ.89.1.8281664 · doi:10.1161/circ.89.1.8281664
  11. 10.1016/S0140-6736(87)93050-9 · DOI · Paper page
  12. 10.1111/j.1365-2796.1993.tb00688.x · DOI
  13. Mänttäri M, Elo O, Frick MH, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, Mäenpää H, Mälkönen M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjöblom T, Nikkilä EA. The Helsinki Heart Study: basic design and randomization procedure. Eur Heart J. 1987;8:1-29.
  14. 10.1055/s-0038-1648481 · DOI
  15. 10.1161/circ.85.5.1572044 · doi:10.1161/circ.85.5.1572044
  16. 10.1093/oxfordjournals.eurheartj.a062547 · DOI · Paper page
  17. Wilhelmsen L Tibblin G Fodor J Werkö L. A multifactorial primary preventive trial in Gothenburg Sweden. In: Larson OA Malmborg RO eds. Coronary Heart Disease and Physical Fitness. Copenhagen: Munksgaard; 1971:266-270.
  18. Dixon WJ ed. BMDP Statistical Software Manual. Berkeley/Los Angeles/Oxford: University of California Press; 1990.
  19. 10.1161/circ.89.2.8313558 · doi:10.1161/circ.89.2.8313558
  20. 10.1111/j.1365-2796.1991.tb00352.x · DOI
  21. 10.1161/atv91.13.10.8399084 · doi:10.1161/atv91.13.10.8399084
  22. 10.1161/atv91.13.1.8422338 · doi:10.1161/atv91.13.1.8422338
  23. 10.1161/atv91.12.1.1310024 · doi:10.1161/atv91.12.1.1310024
  24. 10.1111/j.1365-2796.1994.tb01029.x · DOI
  25. 10.1055/s-2007-1002671 · doi:10.1055/s-2007-1002671

Cited by

See all 188

Metadata

Authors
Tenkanen, L., Mänttäri, M., & Manninen, V.
Venue
Circulation
Published
1995-10
Volume
92
Issue
7
Pages
1779-1785
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2108886453
Cited by
188
References
4
FWCI
6.66
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Some Coronary Risk Factors Related to the Insulin Resistance Syndrome and Treatment With Gemfibrozil: Experience From the Helsinki Heart Study. https://app.cochat.ai/papers/10.1161/01.cir.92.7.1779
The paper
Tenkanen, L., Mänttäri, M., & Manninen, V. (1995). Some Coronary Risk Factors Related to the Insulin Resistance Syndrome and Treatment With Gemfibrozil: Experience From the Helsinki Heart Study. Circulation. https://doi.org/10.1161/01.cir.92.7.1779

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.